Epidemiologic Study of Human Epidermal Growth Factor Receptor 2 Expression in Advanced/Metastatic Gastric Cancer: an Assessment of Human Epidermal Growth Factor Receptor 2 Status in Tumor Tissue Samples of Gastric and Gastro-Esophageal Junction Cancer

PURPOSE: The Trastuzumab for gastric cancer (GC) trial identified human epidermal growth factor receptor 2 (HER2) as a predictor of successful treatment with trastuzumab (HER2 receptor targeting agent) among patients with advanced/metastatic GC. To date, the prevalence of HER2 overexpression in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Kyung Won, Jeon, Taeyong, Kim, Sewon, Kim, Sung Soo, Kim, Kwanghee, Suh, Byoung-Jo, Hwang, Sunhwi, Choi, SeongHee, Ryu, Seungwan, Min, Jae Seok, Lee, Young-Joon, Jee, Ye Seob, Chae, Hyeondong, Yang, Doo Hyun, Lee, Sang Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Gastric Cancer Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362834/
https://www.ncbi.nlm.nih.gov/pubmed/28337363
http://dx.doi.org/10.5230/jgc.2017.17.e6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5362834/
https://www.ncbi.nlm.nih.gov/pubmed/28337363
http://dx.doi.org/10.5230/jgc.2017.17.e6

Ejemplares similares